key: cord-0801903-ab28sjlt authors: Elshazli, Rami M.; Kline, Adam; Elgaml, Abdelaziz; Aboutaleb, Mohamed H.; Salim, Mohamed M.; Omar, Mahmoud; Munshi, Ruhul; Mankowski, Nicholas; Hussein, Mohammad H.; Attia, Abdallah S.; Toraih, Eman A.; Settin, Ahmad; Killackey, Mary; Fawzy, Manal S.; Kandil, Emad title: Gastroenterology manifestations and COVID‐19 outcomes: A meta‐analysis of 25,252 cohorts among the first and second waves date: 2021-02-23 journal: J Med Virol DOI: 10.1002/jmv.26836 sha: d9dcaa108e378ca985b920416171b2d977139b55 doc_id: 801903 cord_uid: ab28sjlt A meta‐analysis was performed to identify patients with coronavirus disease 2019 (COVID‐19) presenting with gastrointestinal (GI) symptoms during the first and second pandemic waves and investigate their association with the disease outcomes. A systematic search in PubMed, Scopus, Web of Science, ScienceDirect, and EMBASE was performed up to July 25, 2020. The pooled prevalence of the GI presentations was estimated using the random‐effects model. Pairwise comparison for the outcomes was performed according to the GI manifestations' presentation and the pandemic wave of infection. Data were reported as relative risk (RR), or odds ratio and 95% confidence interval. Of 125 articles with 25,252 patients, 20.3% presented with GI manifestations. Anorexia (19.9%), dysgeusia/ageusia (15.4%), diarrhea (13.2%), nausea (10.3%), and hematemesis (9.1%) were the most common. About 26.7% had confirmed positive fecal RNA, with persistent viral shedding for an average time of 19.2 days before being negative. Patients presenting with GI symptoms on admission showed a higher risk of complications, including acute respiratory distress syndrome (RR = 8.16), acute cardiac injury (RR = 5.36), and acute kidney injury (RR = 5.52), intensive care unit (ICU) admission (RR = 2.56), and mortality (RR = 2.01). Although not reach significant levels, subgroup‐analysis revealed that affected cohorts in the first wave had a higher risk of being hospitalized, ventilated, ICU admitted, and expired. This meta‐analysis suggests an association between GI symptoms in COVID‐19 patients and unfavorable outcomes. The analysis also showed improved overall outcomes for COVID‐19 patients during the second wave compared to the first wave of the outbreak. (d) reviews, editorial materials, non-peer-reviewed articles, and preprint versions, and (e) articles reporting irrelevant, or insufficient data. Positive GI cases were those who had at least one of the following gastrointestinal symptoms: anorexia, nausea, vomiting, diarrhea, abdominal pain, recent-onset constipation, heartburn, dysgeusia/ageusia, hematemesis, hematochezia, and/or melena. Non-GI controls were defined as asymptomatic cohorts or presenting with respiratory and/or neurologic and/or systemic symptoms, not including any reported GI symptoms. Patients with a severe phenotype should meet at least one of the following three criteria: (a) respiratory distress and respiratory rate higher than 30 per minute; (b) fingertip blood oxygen saturation less than 93% during rest; (c) partial arterial oxygen pressure (PaO 2 )/fraction of inspiration oxygen (FiO 2 ) ≤ 300 mmHg. 13 Regarding pairwise meta-analysis, we conducted five comparisons, including (1) In addition, a subgroup analysis was performed according to the publication date to investigate a potential difference between the first and second waves of the pandemic. The former was defined as patients infected with COVID-19 before May 15, 2020. The latter was defined as patients infected with COVID-19 at or after May 16, 2020. 14,15 May 15 was selected for two reasons: It is closest to the median date of publication of the included 126 studies. It is approximately the date of various re-opening strategies in many geographic areas. Also, studies were categorized according to geographic distribution into Asian and non-Asian studies. Studies' characteristics, patient demographics, and clinical presentation, comorbid conditions, and results of laboratory testing were also retrieved. Complications such as acute respiratory distress syndrome (ARDS), acute cardiac injury, arrhythmias, acute liver injury, acute kidney injury (AKI), shock, and sepsis, degree of severity, intensive care unit (ICU) admission, treatment protocols, length of hospital stay, and outcomes were collected. RME has revised the whole extracted data and resolved any dissonance. All statistical analyses were processed with Comprehensive Meta-Analysis version 3.0 and STATA 16.0, and the results were considered significant at a p value less than .05. Related events or means and standard deviations (SDs) of each arm were extracted. Other statistical variable data, like median and interquartile range (IQR), were converted to means and SDs. One-arm meta-analysis was first performed using the Continuous Random-effects model and the DerSimonian-Laird method. The pooled mean effect size and proportion were estimated for quantitative and binary data, respectively. Next, a two-arms meta-analysis was performed to compare clinical outcomes and admission outcomes between cohorts presented with gastrointestinal manifestations and those without gastrointestinal symptoms. Data were reported as standardized mean difference (SMD), relative risk (RR), or odds ratio (OR), and 95% confidence interval (CI). Heterogeneity was quantified by using I 2 statistics. Articles were considered to have significant heterogeneity between studies when the p value less than .1 or I 2 greater than 50%. 16 Subgroup analysis by the pandemic wave of infection (first/early wave vs. second/late wave) and ethnicity (Asian, American, European, and Mexican) was carried out. Random-effects Meta-regression was performed to identify the influence of potential effect modifiers on the pooled results and explain the heterogeneity between studies. Covariates as geographical distribution and date of publication were employed. Also, publication bias was evaluated by Egger's regression test. 17 3 | RESULTS Systematic search as depicted in Figure 1A yield 125 eligible publications, including 25,252 participants. Articles were published in 11 countries, predominated by China (101 studies; Figure 1B ). They were published from January 24 to July 25, 2020, covering the two COVID-19 pandemic waves. The sample size ranged from 6 to 1452 per article. The basic characteristics of the 125 articles used for one-arm meta-analysis are listed in Table 1 . For pairwise comparisons, 60 articles compared the clinical data, laboratory features, and outcomes of COVID-19 patients with and without GI symptoms (Table 2) . 18, 24, 29, 34, 36, 40, [42] [43] [44] [45] [46] [47] 50, 51, 53, 54, 58, 60, 62, 64, 65, 67, 70, 73, 74, 77, 80, 81, 83, 86, 87, 89, [91] [92] [93] [94] [95] [96] 98, 99, 102, 110, 111, [116] [117] [118] [119] [121] [122] [123] [124] 130, 132, 133, 142 Of these, 26 studies compared severe/critical COVID-19 patients versus mild cases, 18, 34, 43, 44, 46, 47, 51, 53, 62, 67, 70, 73, 74, 77, 92, 93, 98, 99, 102, 111, [117] [118] [119] 121, 122, 133 four articles compared between hospitalized patients and those not required hospitalization, 45, 80, 89, 142 five studies compared ICU admitted patients versus floor hospitalization, 50, 80, 96, 116, 142 11 publications compared between those who died with those who survived, 29, 34, 58, 60, 83, 91, 94, 110, 117, 123, 137 Figure 2) . A pooled one-arm meta-analysis of detailed demographic, clinical, and laboratory features of COVID-19 patients with gastrointestinal presentations is demonstrated in Table S1 . As depicted in Figure 3 , subgroup analysis by the pandemic waves revealed a higher prevalence of acute cardiac injury and ICU admission (both p < .001) in the first wave. In contrast, second wave articles reported higher ARDS frequencies, AKI, mechanical ventilation use, and a higher risk of mortality (all p < .001). Pairwise comparative analysis of COVID-19 cases with and without GI symptoms is shown in Table 3 Figure 4 ). Meta-regression analysis revealed that heterogeneity in mechanical ventilation parameters was partly related to geographical region (p = .012; Table S2 ). SARS-CoV-2 has been found to infect multiple organ systems and is not exclusively a respiratory virus, as initially thought. Gastrointestinal symptoms have previously been reported to worsen outcomes in COVID-19 patients, although it remains unclear as contradictory research also exists. 7 This relatively wide scoped meta-analysis showed that GI symptoms were present in about one-fifth of the study population and were associated with higher rates of adverse outcomes such as ICU admission and/or mortality. Furthermore, patients with GI symptoms were more likely to develop AKIs associated with worse outcomes in COVID-19 patients. 143, 144 Similarly, GI symptoms correlated with a greater risk of cardiac injury, another poor prognostic factor for hospitalized patients with COVID-19. 145, 146 The strong correlation between GI symptoms and the most un- were ventilated less often than non-Asians. However, this might be due to the differences in medical practices between these geographic areas. Despite the discrepancy in ventilation rates, there were no differences in ARDS, AKI, or acute cardiac injury rates. Admission outcomes, including mortality, were likewise equal among Asian versus nonAsian patients. Pandemics have historically come in waves with differing severities and lengths of time between them. 150 Consequentially, it is .093 Note: The random-effects model was applied. Abbreviations: ACE/ARB, angiotensin-converting enzyme and an angiotensin receptor blocker; ALP, alkaline phosphatase; ALT, alanine aminotransferase; APTT, ativated partial thromboplastin time; ARDS, acute respiratory distress syndrome; AST, aspartate aminotransferase; BMI, body mass index; BUN, blood urea nitrogen; CD, cluster of differentiation; CI, confidence interval; CRP, C-reactive protein; CRRT, continuous renal replacement therapy; COPD, chronic obstructive pulmonary disease; Duration of viral shedding, The time from diagnosis date to the day before first negative conversion of two consecutive negative results of RT-PCR; ECMO, extracorporeal membrane oxygenation; eGFR, estimated glomerular filtration rate; ESR, erythrocyte sedimentation rate; GGT, Gamma-Glutamyl transferase; I 2 , the ratio of true heterogeneity to total observed variation; IMV, invasive mechanical ventilation; IV, inverse variance; MD, mean difference; MH, Mantel-Haenszel; pub bias, publication bias assessed by Egger's test; NIV, noninvasive mechanical ventilation; NLR, neutrophil-to-Lymphocyte ratio; NSAID, nonsteroidal anti-inflammatory drugs; NT-proBNP, N-terminal-pro hormone B-type natriuretic peptide; OR, odds ratio; PaCO 2 , The partial pressure of cardon dioxide; PaO 2 , The partial pressure of oxygen; PaO 2 :FiO 2 ratio, the ratio of arterial oxygen partial pressure to fractional inspired oxygen; pH, a measure of hydrogen ion concentration, the acidity or alkalinity of blood; RR, relative risk; RBCs, red blood cells or erythrocytes; RT-PCR, reverse transcription-polymerase chain reaction; SMD, standardized mean difference; SpO 2 , oxygen saturation; WBCs, white blood cells or leukocytes;. F I G U R E 3 Subgroup analysis for pooled one-arm meta-analysis of COVID-19 outcomes by the pandemic wave. Odds ratio and 95% confidence intervals were reported. p values comparing the first and second waves were estimated using Student's t-test. ARDS, acute respiratory distress syndrome; COVID-19, coronavirus disease 2019 compared with first wave patients with GI symptoms. This particular analytic method allowed a comparison between the more acutely ill patients showing GI symptoms, which demonstrated more accurate results than the pooled prevalence results. Fan et al. 15 found that mortality rates in the second wave of the pandemic decreased sharply even among countries that saw a greater caseload than the first wave. In the studies analyzed for this meta-analysis, there was an overall lower rate of complications and mortality in the GI symptom-positive cohort of the second wave providing evidence of improved management of patients with COVID-19, which agrees with the findings of Fan et al. 15 This metaanalysis is further evidence of the decrease in mortality outcome that might be due to an improvement in the clinical handling of the disease. While many treatments have proven effective at improving the disease course in smaller trials, it is reassuring to see a largescale improvement in morbidity and mortality in severe cases. This is most likely due to the combined efforts of medical providers and public health officials in identifying severe COVID-19 cases earlier and intervening appropriately. Also, likely contributing factors are the improvements in therapeutics, treatment algorithms, and familiarity with the disease course. A limitation of this meta-analysis was that it reviewed predominately retrospective studies making randomization impossible. Since not all studies had the primary goal of evaluating GI symptoms' impact on COVID-19 outcomes, differences in the recording of symptoms between studies could be potentially present. While including studies throughout the world was beneficial for increasing the findings' generalizability, doing so might affect the data collected from differently impacted countries. This limitation was addressed by controlling analysis for a geographic area. The findings of this meta-analysis suggest that there is an association between gastrointestinal symptoms in patients with COVID-19 and worse disease outcomes, especially in the first wave of infection. These symptoms were found to be common, appearing in approximately one-fifth of studied patients. Screening patients for GI symptoms is quick and may benefit providers by offering a simple method for stratifying patient risk levels. By grouping the studies in the first wave and second wave categories, the analysis showed overall improved outcomes for patients who have more recently been treated for COVID-19 regardless of their GI affection. This work is dedicated to the soul of our beloved Professor Dr. Akram El Awady, the president and godfather of Horus University -Egypt, who passed away on February 3rd, 2021. We will miss you and love you always. Your love will light our way and your memory will be forever in our hearts. We will grasp you in our hearts till we can cuddle you again in Heaven. The authors declare that there are no conflict of interests. Rami M. Elshazli Covid-19 and the digestive system Rapid progression to acute respiratory distress syndrome: review of current understanding of critical illness from coronavirus disease 2019 (COVID-19) infection Hematological findings and complications of COVID-19 Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a casecontrol study gastrointestinal features in COVID-19 and the possibility of faecal transmission The mechanism and treatment of gastrointestinal symptoms in patients with COVID-19 Meta-analysis of outcomes of patients with COVID-19 infection with versus without gastrointestinal symptoms Gastrointestinal and liver manifestations in patients with COVID-19 Respiratory influenza virus infection induces intestinal immune injury via microbiotamediated Th17 cell-dependent inflammation Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis Is SARS-CoV-2 also an enteric pathogen with potential Fecal-Oral transmission: a COVID-19 virological and clinical review Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation Clinical characteristics and outcomes of patients with severe covid-19 with diabetes First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment Decreased case fatality rate of COVID-19 in the second wave: a study in 53 countries or regions Measuring inconsistency in meta-analyses Bias in meta-analysis detected by a simple, graphical test The clinical and chest CT features associated with severe and critical COVID-19 pneumonia Covid-19 digestive system involvement and clinical outcomes in a large academic Clinical characteristics of COVID-19 patients with gastrointestinal symptoms: an analysis of seven patients in China National French survey of COVID-19 symptoms in people aged 70 and over A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study Experimental treatment with favipiravir for COVID-19: an open-label control study Clinical features and outcomes of COVID-19 patients with gastrointestinal symptoms Management of upper GI bleeding in patients with COVID-19 pneumonia Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China Persistent viral presence determines the clinical course of the disease in COVID-19 Are gastrointestinal symptoms specific for coronavirus 2019 infection? A prospective case-control study from the United States The characteristics and outcomes of 681 severe cases with COVID-19 in China Clinical progression of patients with COVID-19 in Shanghai Clinical course of severe and critically ill patients with coronavirus disease 2019 (COVID-19): a comparative study Clinical characteristics of rehospitalized patients with COVID-19 in China Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China Associations of clinical characteristics and treatment regimens with the duration of viral RNA shedding in patients with COVID-19 The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients High prevalence of concurrent gastrointestinal manifestations in patients with severe acute respiratory syndrome coronavirus 2: Early experience From California Positive results for patients with COVID-19 discharged form hospital in Chongqing A retrospective study of the initial 25 COVID-19 patients in Luoyang, China Faecal calprotectin indicates intestinal inflammation in COVID-19 Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients Analysis of gastrointestinal and hepatic manifestations of SARS-CoV-2 infection in 892 patients in Queens The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: a retrospective study in Suzhou China Clinical characteristics of coronavirus disease 2019 in China Gastrointestinal and hepatic manifestations of 2019 novel Coronavirus disease in a large cohort of infected patients from New York: clinical implications Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes Analysis of factors affecting the prognosis of COVID-19 patients and viral shedding duration Mask wearing in pre-symptomatic patients prevents SARS-CoV-2 transmission: an epidemiological analysis COVID-19 patients with hypertension have more severity condition, and ACEI/ARB treatment have no infulence on the clinical severity and outcome Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical characteristics and predictors of disease progression in severe patients with COVID-19 infection in Jiangsu Province, China: a descriptive study Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients Clinical characteristics of patients diagnosed with COVID-19 in Beijing Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms Gastrointestinal complications in critically ill patients with COVID-19 Clinical features of 1487 COVID-19 patients with outpatient management in the Greater Paris: the COVID-call study A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus disease (COVID-19) in Wuhan and outside Wuhan, China Risk factors for predicting mortality in elderly patients with COVID-19: a review of clinical data in China Clinical characteristics of emergency surgery patients-infected COVID-19 pneumonia in Wuhan Clinical characteristics and outcomes of 74 patients with severe or critical COVID-19 The characteristics of household transmission of COVID-19 Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan Neurosensory dysfunction: a diagnostic marker of early COVID-19 Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019 Epidemiological characteristics of COVID-19 patients in convalescence period Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 Clinically significant portal hypertension in cirrhosis patients with COVID-19: clinical characteristics and outcomes Patients of COVID-19 may benefit from sustained lopinavir-combined regimen and the increase of eosinophil may predict the outcome of COVID-19 progression Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10 patients with COVID-19 in Macau Viral dynamics of SARS-CoV-2 across a spectrum of disease severity in COVID-19 Don't overlook digestive symptoms in patients with 2019 novel coronavirus disease (COVID-19) Assessing risk factors for SARS-CoV-2 infection in patients presenting with symptoms in Shanghai, China: a multicentre, observational cohort study Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China Gastrointestinal symptoms and coronavirus disease 2019: a case-control study from the United States Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding duration Clinical and epidemiological characteristics of patients diagnosed with COVID-19 in a tertiary care center in Mexico City: a prospective cohort study Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea Clinical course of coronavirus disease 2019 in 11 patients after thoracic surgery and challenges in diagnosis Abdominal pain: a real challenge in novel COVID-19 infection Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China: a retrospective cohort study Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients Prevalence and characteristics of gastrointestinal symptoms in patients with SARS-CoV-2 infection in the United States: a multicenter cohort study Initial gastrointestinal manifestations in patients with severe acute respiratory syndrome coronavirus 2 infection in 112 patients from Veracruz in Southeastern Mexico Clinical factors, preventive behaviours and temporal outcomes associated with COVID-19 infection in health professionals at a spanish hospital Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Risk factors for mortality in 244 older adults with COVID-19 in Wuhan, China: a retrospective study Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Clinical features of 95 sequential hospitalised patients with novel coronavirus 2019 disease (COVID-19), the first UK cohort Enteric involvement in hospitalised patients with COVID-19 outside Wuhan Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China Imaging manifestations and diagnostic value of chest CT of coronavirus disease 2019 (COVID-19) in the Xiaogan area Epidemiological and clinical features of 125 hospitalized patients with COVID-19 in Fuyang Clinical characteristics of noncritically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19 Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui Clinical characteristics of imported cases of coronavirus disease 2019 (COVID-19) in Jiangsu Province: a multicenter descriptive study A predictive nomogram for predicting improved clinical outcome probability in patients with COVID-19 in Zhejiang Province Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes Factors associated with prolonged viral RNA shedding in patients with COVID-19 Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2 Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): a multi-center study in Wenzhou city Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 The implications of preliminary screening and diagnosis: clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan Clinical characteristics of the coronavirus disease 2019 (COVID-19) outbreak on a cruise ship Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore Clinical features of COVID-19 and influenza: a comparative study on Nord Franche-Comte cluster Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: a multicentre, retrospective study Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan Outcomes of novel coronavirus disease 2019 (COVID-19) infection in 107 patients with cancer from Wuhan Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China Poor-sleep is associated with slow recovery from lymphopenia and an increased need for ICU care in hospitalized patients with COVID-19: a retrospective cohort study Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan Diarrhea and altered inflammatory cytokine pattern in severe coronavirus disease 2019: impact on disease course and in-hospital mortality Analysis of gastrointestinal symptoms in 80 patients with coronavirus disease 2019. Zhonghua wei Zhong Bing ji jiu yi xue Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias The time sequences of respiratory and rectal viral shedding in patients with coronavirus disease 2019 Relation between chest CT findings and clinical conditions of coronavirus disease (COVID-19) pneumonia: a multicenter study Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020 Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study The duration of viral shedding of discharged patients with severe COVID-19 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet Effect of gastrointestinal symptoms in patients with COVID-19 Clinical features of COVID-19 convalescent patients with re-positive nucleic acid detection Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019 Characteristics of liver function in patients with SARS-CoV-2 and chronic HBV coinfection Association of digestive symptoms and hospitalization in patients with SARS-CoV-2 infection. medRxiv Kidney disease is associated with inhospital death of patients with COVID-19 AKI in hospitalized patients with COVID-19 Predictors of mortality in hospitalized COVID-19 patients: a systematic review and meta-analysis Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019: A Systematic Review and Metaanalysis Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and metaanalysis Emergence of European and North American mutant variants of SARS-CoV-2 in South-East Asia COVID-19 epidemic 'waves'. Cebmnet. 2020:30 Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves The data that support the findings of this study are available in the manuscript and the supplementary materials.